Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging Variables

References

1. 1.↵
   1. DeAngelis LM

   . Brain tumors. N Engl J Med 2001;344:114–23

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Bisdas S,
   2. Kirkpatrick M,
   3. Giglio P,
   4. et al

   . Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? AJNR Am J Neuroradiol 2009;30:681–88

   Abstract/FREE Full Text
3. 3.↵
   1. Lacroix M,
   2. Abi-Said D,
   3. Fourney DR,
   4. et al

   . A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–98

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Law M,
   2. Young RJ,
   3. Babb JS,
   4. et al

   . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–98. Epub 2008 Mar 18

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Mills SJ,
   2. Patankar TA,
   3. Haroon HA,
   4. et al

   . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58

   Abstract/FREE Full Text
6. 6.↵
   1. Lev MH,
   2. Ozsunar Y,
   3. Henson JW,
   4. et al

   . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol. 2004;25:214–21

   Abstract/FREE Full Text
7. 7.↵
   1. Oh J,
   2. Henry RG,
   3. Pirzkall A,
   4. et al

   . Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19:546–54

   CrossRefPubMed
8. 8.↵
   1. Leimgruber A,
   2. Ostermann S,
   3. Yeon EJ,
   4. et al

   . Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. Int J Radiat Oncol Biol Phys 2006;64:869–75. Epub 2005 Oct 13

   PubMed
9. 9.↵
   1. Kantardzic M

   . Data Mining: Concepts, Models, Methods, and Algorithms. John Wiley & Sons; 2003
10. 10.↵
    1. Verma R,
    2. Zacharaki EI,
    3. Ou Y,
    4. et al

    . Multi-parametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol 2008;15:966–77

    CrossRefPubMed
11. 11.↵
    1. Zacharaki EI,
    2. Wang S,
    3. Chawla S,
    4. et al

    . Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009;62:1609–18

    CrossRefPubMed
12. 12.↵
    1. Hall M,
    2. Frank E,
    3. Holmes G,
    4. et al

    . The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter. 2009;11:10–18.

    CrossRef
13. 13.↵
    1. Zhang Y,
    2. Brady M,
    3. Smith S

    . Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Scott JN,
    2. Rewcastle NB,
    3. Brasher PM,
    4. et al

    . Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999;46:183–88

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Ohgaki H,
    2. Dessen P,
    3. Jourde B,
    4. et al

    . Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892–99

    Abstract/FREE Full Text
16. 16.↵
    1. Filippini G,
    2. Falcone C,
    3. Boiardi A,
    4. et al

    . Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 2008;10:79–87

    Abstract/FREE Full Text
17. 17.↵
    1. Sonoda Y,
    2. Kumabe T,
    3. Watanabe M,
    4. et al

    . Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 2009;151:1349–58

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Glas M,
    2. Happold C,
    3. Rieger J,
    4. et al

    . Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol 2009;27:1257–61

    Abstract/FREE Full Text
19. 19.↵
    1. Guyon I,
    2. Elisseeff A

    . An introduction to variable and feature selection. Journal of Machine Learning Research 2003;3:1157–82

    CrossRef
20. 20.↵
    1. Laguna M,
    2. Mart R

    . Scatter Search: Methodology and Implementations in C. Norwell, Massachusetts: Kluwer Academic Press; 2003
21. 21.↵
    1. Kohavi R,
    2. John GH

    . Wrappers for feature subset selection. Artificial Intelligence 1997;97:273–324

    CrossRefWeb of Science
22. 22.↵
    1. Gandhi GM,
    2. Srivatsa SK

    . Adaptive machine learning algorithm (AMLA) using J48 classifier for an NIDS environment. Advances in Computational Sciences and Technology 2010;3:291–304
23. 23.↵
    1. Ramnarayan R,
    2. Dodd S,
    3. Das K,
    4. et al

    . Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter. J Neurol Sci 2007;260:49–56. Epub 2007 May 1

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Usefulness of diffusion weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9:53–60

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Al-Okaili RN,
    2. Krejza J,
    3. Woo JH,
    4. et al

    . Intra-axial brain masses: MR imaging-based diagnostic strategy—initial experience. Radiology 2007;243:539–50

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Pope WB,
    2. Sayre J,
    3. Perlina A,
    4. et al

    . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466–74

    Abstract/FREE Full Text
27. 27.↵
    1. Principi M,
    2. Italiani M,
    3. Guiducci A,
    4. et al

    . Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis, and angiogenesis in glioblastomas and grade 1 meningiomas. Neuroradiology 2003;45:205–11. Epub 2003 Mar 5

    PubMedWeb of Science
28. 28.↵
    1. Sundgren PC,
    2. Junck L,
    3. Meyer CR,
    4. et al

    . Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol 2010;28:2293–99

    Abstract/FREE Full Text
29. 29.↵
    1. Kanner AA,
    2. Staugaitis SM,
    3. Castilla EA,
    4. et al

    . The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making. J Neurosurg 2006;104:542–50

    PubMed
30. 30.↵
    1. Cairncross JG,
    2. Ueki K,
    3. Zlatescu MC,
    4. et al

    . Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473–79

    Abstract/FREE Full Text